Quantum BioPharma Ltd. (QNTM) — Fundamental Analysis & Key Financial Ratios

Quantum BioPharma Ltd. (QNTM) — Price $3.65 HealthcareBiotechnology — NASDAQ

Latest reported results:

Quantum BioPharma Ltd. (QNTM) is a publicly traded company in the Healthcare — Biotechnology industry listed on NASDAQ. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.

Quantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses on addressing complex neurodegenerative, inflammatory, and metabolic conditions, alongside alcohol use disorder, with its pipeline featuring a range of drug candidates at varying stages of development.

Analysis: , founder of Kaplio · Data: Financial Modeling Prep · Updated

Price

Price$3.65
Market Cap$23M
ExchangeNASDAQ
CountryCA

Financial Health

Piotroski F-Score1
Altman Z-Score-26.98

What to look at in Biotech

Most small biotechs lose money. Analysing them with P/E makes no sense — look at cash and pipeline.

Peer Comparison

SymbolCompanyMarket CapP/EP/BROE
QNTMQuantum BioPharma Ltd.$23M
0QZU.LVertex Pharmaceuticals Incorporated$131.8B
VRTXVertex Pharmaceuticals Incorporated$130.3B29.686.4523.3%
0R2M.LRegeneron Pharmaceuticals, Inc.$84.0B
REGNRegeneron Pharmaceuticals, Inc.$79.8B18.792.5713.8%
ARGXargenx SE$61.2B36.307.4021.7%
MRNAModerna, Inc.$57.8B1.34-39.2%
RVMDRevolution Medicines, Inc.$41.7B15.96-96.4%

Explore sector: Healthcare · Biotechnology

More sections of QNTM: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks